5 Key Takeaways

• 1

  Pathology has evolved to include guiding ancillary testing and interpreting biomarkers, but workflows have not kept pace with modern medical demands.

• 2

  Virtual staining enhances traditional pathology by providing faster, non-destructive biomarker analysis without replacing established techniques like immunohistochemistry.

• 3

  AI has begun to impact pathology by predicting biomarker status from H&E images, but early models often lack spatial resolution of biomarker expression.

• 4

  Virtual staining generates spatially resolved maps of biomarker expression at the individual cell level, improving interpretability and insight into tissue structure.

• 5

  This approach allows for scalable biomarker analysis from a single H&E slide, reducing tissue consumption and turnaround times while enhancing patient triaging.